Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry

• Published in: Life (Basel, Switzerland) Vol. 12; no. 9; p. 1300
• Main Authors: Upadhyai, Priyanka, Shenoy, Pooja U., Banjan, Bhavya, Albeshr, Mohammed F., Mahboob, Shahid, Manzoor, Irfan, Das, Ranajit
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 24-08-2022; MDPI
• Subjects: Airway management; Asymptomatic; Biomarkers; Chemokines; Chromosomes; Clinical outcomes; common genetic variants; Complications; Consortia; Coronaviruses; COVID-19; COVID-19 host genetics; Datasets; Disease; exome-wide association study for COVID-19 patients; Genes; Genetic diversity; Genetic variability; Genetic variance; genetic variation in COVID-19 patients; Genomes; Genotype & phenotype; Hospitalization; Interferon; Irritable bowel syndrome; Patients; Population; Proteins; Severe acute respiratory syndrome coronavirus 2; Single-nucleotide polymorphism; Viral infections; Italy
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life12091300

Host genetic variability plays a pivotal role in modulating COVID-19 clinical outcomes. Despite the functional relevance of protein-coding regions, rare variants located here are less likely to completely explain the considerable numbers of acutely affected COVID-19 patients worldwide. Using an exome-wide association approach, with individuals of European descent, we sought to identify common coding variants linked with variation in COVID-19 severity. Herein, cohort 1 compared non-hospitalized (controls) and hospitalized (cases) individuals, and in cohort 2, hospitalized subjects requiring respiratory support (cases) were compared to those not requiring it (controls). 229 and 111 variants differed significantly between cases and controls in cohorts 1 and 2, respectively. This included FBXO34, CNTN2, and TMCC2 previously linked with COVID-19 severity using association studies. Overall, we report SNPs in 26 known and 12 novel candidate genes with strong molecular evidence implicating them in the pathophysiology of life-threatening COVID-19 and post-recovery sequelae. Of these few notable known genes include, HLA-DQB1, AHSG, ALOX5AP, MUC5AC, SMPD1, SPG7, SPEG,GAS6, and SERPINA12. These results enhance our understanding of the pathomechanisms underlying the COVID-19 clinical spectrum and may be exploited to prioritize biomarkers for predicting disease severity, as well as to improve treatment strategies in individuals of European ancestry.